Quad Technologies: Quad wins patent for alternative to magnetic beads in CAR T separation
Cell therapy makers need scalable technologies that do not rely on magnetic beads for separation or culture, says Quad Technologies.
Read full article »
CEO
Quad is a developer and provider of cell separation and activation technology for cell and gene therapy applications.
Read more